XML 27 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Net revenue $ 5,004 $ 10,884 $ 56,590 $ 46,743
Net operating costs and expenses:        
Cost of revenue 1,384 3,840 16,689 15,681
Research and development 2,456 3,108 9,641 12,746
Selling, general and administrative 28,060 29,278 119,016 119,641
Intangible amortization 1,002 1,027 4,031 4,106
Legal settlements 0 (6,891) (9,391) 0
Total net operating costs and expenses 32,902 30,362 139,986 152,174
Loss from operations (27,898) (19,478) (83,396) (105,431)
Other (income) expense, net:        
(Gain) loss on derivative liability (10,409) 457 (17,378) 512
Change in fair value of debt and liability instruments 6,114 3,905 4,782 7,189
Interest expense, net 2,481 531 1,963 1,068
(Gain) loss on foreign currency exchange (4) 6 45 118
Total other (income) expense, net (1,818) 4,899 (10,588) 8,887
Loss before income taxes     (72,808) (114,318)
Income tax (benefit) expense     (1) 13
Net loss $ (26,080) $ (24,377) $ (72,807) $ (114,331)
Net loss per share attributable to common stockholders - basic and diluted        
Net loss per share attributable to common stockholders - basic $ (2.26) $ (8.33) $ (7.24) $ (44.86)
Net loss per share attributable to common stockholders - diluted $ (2.26) $ (8.33) $ (8.05) $ (44.86)
Weighted average number of shares during the period - basic and diluted        
Weighted average number of shares during the period-basic 11,565 2,926 10,061,000 3,722,000
Weighted average number of shares during the period -diluted 11,565 2,926 10,145,000 3,722,000
Comprehensive loss:        
Net loss $ (26,080) $ (24,377) $ (72,807) $ (114,331)
Other comprehensive income:        
Changes in fair value attributable to instrument-specific credit risk     6,317 0
Total other comprehensive income     6,317 0
Comprehensive loss     $ (66,490) $ (114,331)